(Q44036150)

29 November 2017

title

Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection (English)

1 reference

29 November 2017

1 reference

Ian E Haines

1

1 reference

29 November 2017

George L Gabor Miklos

series ordinal

2

1 reference

29 November 2017

language of work or name

English

0 references

publication date

3 October 2013

1 reference

Journal of the National Cancer Institute

29 November 2017

published in

1 reference

29 November 2017

volume

105

1 reference

29 November 2017

issue

20

1 reference

29 November 2017

page(s)

1534-1539

1 reference

Prostate-cancer mortality at 11 years of follow-up

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

ERSPC and PLCO prostate cancer screening studies: what are the differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Radical prostatectomy versus observation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Natural history of early, localized prostate cancer: a final report from three decades of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

The role of primary androgen deprivation therapy in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Survival following primary androgen deprivation therapy among men with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT248

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJT248

1 reference

29 November 2017

1 reference